Richard Marcotte

2.5k total citations
20 papers, 1.1k citations indexed

About

Richard Marcotte is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Richard Marcotte has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Physiology. Recurrent topics in Richard Marcotte's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Ubiquitin and proteasome pathways (4 papers) and Telomeres, Telomerase, and Senescence (3 papers). Richard Marcotte is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Ubiquitin and proteasome pathways (4 papers) and Telomeres, Telomerase, and Senescence (3 papers). Richard Marcotte collaborates with scholars based in Canada, United States and Russia. Richard Marcotte's co-authors include Eugenia Wang, William J. Muller, Gordon B. Mills, Chantale Lacelle, L. Bruno Ruest, Benjamin G. Neel, Jason Moffat, Bryan T. Hennessy, James R. Woodgett and Rachelle L. Dillon and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard Marcotte

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Marcotte Canada 14 834 260 206 136 112 20 1.1k
Daniel T. Dransfield United States 18 780 0.9× 283 1.1× 223 1.1× 85 0.6× 139 1.2× 46 1.2k
Toshinori Hyodo Japan 21 781 0.9× 225 0.9× 171 0.8× 77 0.6× 114 1.0× 47 1.1k
Keiko Doi Japan 20 566 0.7× 155 0.6× 199 1.0× 85 0.6× 118 1.1× 51 877
Concepción Jiménez Spain 11 788 0.9× 196 0.8× 173 0.8× 82 0.6× 208 1.9× 12 1.2k
Ariel Pribluda Israel 7 688 0.8× 190 0.7× 135 0.7× 90 0.7× 121 1.1× 11 912
Edison Liu United States 15 730 0.9× 352 1.4× 200 1.0× 223 1.6× 157 1.4× 25 1.2k
Chul‐Woong Chung South Korea 12 829 1.0× 306 1.2× 112 0.5× 140 1.0× 159 1.4× 20 1.1k
Gretchen Argast United States 17 1.1k 1.3× 357 1.4× 223 1.1× 96 0.7× 205 1.8× 26 1.6k
Vanesa Lafarga Spain 18 1.2k 1.4× 368 1.4× 126 0.6× 78 0.6× 83 0.7× 32 1.4k
Ulrike Rennefahrt Germany 14 897 1.1× 221 0.8× 204 1.0× 68 0.5× 99 0.9× 19 1.2k

Countries citing papers authored by Richard Marcotte

Since Specialization
Citations

This map shows the geographic impact of Richard Marcotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Marcotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Marcotte more than expected).

Fields of papers citing papers by Richard Marcotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Marcotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Marcotte. The network helps show where Richard Marcotte may publish in the future.

Co-authorship network of co-authors of Richard Marcotte

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Marcotte. A scholar is included among the top collaborators of Richard Marcotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Marcotte. Richard Marcotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romero, Hugo Grisales, Marie‐Eve Lalonde, Kathie Béland, et al.. (2024). CRISPR Screens Identify Key Regulators of NK Cell Cytotoxicity in Cancer Therapy. The Journal of Immunology. 212(1_Supplement). 0445_5642–0445_5642.
2.
Lalonde, Marie‐Eve, et al.. (2022). Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia. Haematologica. 108(2). 382–393. 13 indexed citations
3.
Tibiche, Chabane, Jinfeng Zou, André Nantel, et al.. (2019). Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. npj Precision Oncology. 3(1). 28–28. 16 indexed citations
4.
Nair, Nishanth Ulhas, Avinash Das, Richard Marcotte, et al.. (2019). Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival. Scientific Reports. 9(1). 10989–10989. 24 indexed citations
5.
Marcotte, Richard, Azin Sayad, Kevin R. Brown, et al.. (2016). Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance. Cell. 164(1-2). 293–309. 296 indexed citations
6.
Marcotte, Richard, et al.. (2015). Abstract A2-07: Integrative functional genomics of breast cancer. Cancer Research. 75(22_Supplement_1). A2–7. 2 indexed citations
7.
Marcotte, Richard, et al.. (2015). Abstract PR14: Integrative functional genomics of breast cancer. Cancer Research. 75(22_Supplement_2). PR14–PR14. 2 indexed citations
8.
Pal, Ranjana, Zubaidah M. Ramdzan, Simran Kaur, et al.. (2015). CUX2 Protein Functions as an Accessory Factor in the Repair of Oxidative DNA Damage. Journal of Biological Chemistry. 290(37). 22520–22531. 46 indexed citations
9.
Cullis, Jane, David Meiri, María José Sandí, et al.. (2014). The RhoGEF GEF-H1 Is Required for Oncogenic RAS Signaling via KSR-1. Cancer Cell. 25(2). 181–195. 76 indexed citations
10.
Marcotte, Richard, Harvey W. Smith, Virginie Sanguin‐Gendreau, Rosalie McDonough, & William J. Muller. (2011). Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis. Proceedings of the National Academy of Sciences. 109(8). 2808–2813. 47 indexed citations
11.
Marcotte, Richard, et al.. (2009). c-Src Associates with ErbB2 through an Interaction between Catalytic Domains and Confers Enhanced Transforming Potential. Molecular and Cellular Biology. 29(21). 5858–5871. 50 indexed citations
12.
Dillon, Rachelle L., Richard Marcotte, Bryan T. Hennessy, et al.. (2009). Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression. Cancer Research. 69(12). 5057–5064. 148 indexed citations
13.
Marcotte, Richard & William J. Muller. (2008). Signal Transduction in Transgenic Mouse Models of Human Breast Cancer—Implications for Human Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 13(3). 323–335. 38 indexed citations
14.
15.
Marcotte, Richard, Chantale Lacelle, & Eugenia Wang. (2004). Senescent fibroblasts resist apoptosis by downregulating caspase-3. Mechanisms of Ageing and Development. 125(10-11). 777–783. 114 indexed citations
16.
Marcotte, Richard, et al.. (2003). hMad4, c‐Myc endogenous inhibitor, induces a replicative senescence‐like state when overexpressed in human fibroblasts. Journal of Cellular Biochemistry. 89(3). 576–588. 12 indexed citations
17.
Ruest, L. Bruno, Richard Marcotte, & Eugenia Wang. (2002). Peptide Elongation Factor eEF1A-2/S1 Expression in Cultured Differentiated Myotubes and Its Protective Effect against Caspase- 3-mediated Apoptosis. Journal of Biological Chemistry. 277(7). 5418–5425. 113 indexed citations
18.
Marcotte, Richard, et al.. (2002). Microarray Analysis of E-Box Binding-Related Gene Expression in Young and Replicatively Senescent Human Fibroblasts. Analytical Biochemistry. 302(1). 38–51. 29 indexed citations
19.
Lacelle, Chantale, et al.. (2002). Alterations in TNF‐ and IL‐related gene expression in space‐flown WI38 human fibroblasts. The FASEB Journal. 16(8). 899–901. 41 indexed citations
20.
Wang, Eugenia, Richard Marcotte, & Emmanuel Petroulakis. (1999). Signaling pathway for apoptosis: A racetrack for life or death. Journal of Cellular Biochemistry. 75(S32). 95–102. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel T. Dransfield Breakdown of academic impact, for papers by Toshinori Hyodo Breakdown of academic impact, for papers by Keiko Doi Breakdown of academic impact, for papers by Concepción Jiménez Breakdown of academic impact, for papers by Ariel Pribluda Breakdown of academic impact, for papers by Edison Liu Breakdown of academic impact, for papers by Chul‐Woong Chung Breakdown of academic impact, for papers by Gretchen Argast Breakdown of academic impact, for papers by Vanesa Lafarga Breakdown of academic impact, for papers by Ulrike Rennefahrt
Rankless by CCL
2026